CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies

Clinical trial NCT04282174 · WITHDRAWN

Trial details

NCT number: NCT04282174
Sponsor: Baptist Health South Florida
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Diseases Hematologic Malignancy Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Myelogenous Leukemia Chronic Lymphocytic Leukemia

Start date: 2022-09-01
Primary completion: 2030-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.